Cardinal Health is working with advisers to scope out interest in its nuclear medicine business for a potential sale of the unit, Bloomberg’s Dinesh Nair and Michelle F. Davis report. According to people familiar with the matter, several private equity firms are mulling offers and the business could fetch a value of more than $1B in a sale. Cardinal could still decide to keep the unit, the people caution. Reference Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CAH:
- Cardinal Health price target lowered to $77 from $82 at Deutsche Bank
- Cardinal Health, Signify Health collaborate on in-home health management
- Unusually active option classes on open March 2nd
- Cardinal Health, RxLive collaborate to enhance connectivity between providers
- Cardinal Health Board of Directors Approves Quarterly Dividend
Questions or Comments about the article? Write to editor@tipranks.com